Apyx Medical (APYX) Total Non-Current Liabilities (2010 - 2026)

Apyx Medical has reported Total Non-Current Liabilities for 15 years, with the latest figure at $49.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 0.71% year-over-year to $49.6 million; the trailing twelve-month figure through Mar 2026 stood at $49.6 million (up 0.71% YoY), and the FY2025 full-year result was $51.7 million, up 2.81% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $49.6 million, down from $51.7 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $52.1 million in Q4 2023, with the low at $12.9 million in Q3 2022.
• Historically, Total Non-Current Liabilities has averaged $37.0 million across 5 years, with a median of $49.3 million in 2024.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities retreated 5.12% — and 2023, when it surged 277.65%.
• Apyx Medical's Total Non-Current Liabilities stood at $13.8 million in 2022, then surged by 277.65% to $52.1 million in 2023, then slipped by 3.59% to $50.2 million in 2024, then advanced by 2.81% to $51.7 million in 2025, then retreated by 4.0% to $49.6 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $49.6 million (Q1 2026), $51.7 million (Q4 2025), and $51.0 million (Q3 2025), per Business Quant data.